Long-Term Outcomes of the Knee and Hip Arthroplasties in Patients with Alkaptonuria
- PMID: 32875021
- PMCID: PMC7451899
- DOI: 10.1016/j.artd.2020.07.037
Long-Term Outcomes of the Knee and Hip Arthroplasties in Patients with Alkaptonuria
Erratum in
-
Erratum to 'Long-Term Outcomes of the Knee and Hip Arthroplasties in Patients with Alkaptonuria' [Arthroplasty Today. Volume 6, Issue 4, December 2020, Pages 689-693].Arthroplast Today. 2024 Nov 16;30:101579. doi: 10.1016/j.artd.2024.101579. eCollection 2024 Dec. Arthroplast Today. 2024. PMID: 39802409 Free PMC article.
Abstract
Alkaptonuria is a rare autosomal recessive metabolic disorder. It is characterized by the accumulation of homogentisic acid in the body due to a lack of enzymes that degrade it. Over time, it results in joint degeneration and eventually leads to ochronosis. Ochronosis refers to bluish-black discoloration of connective and other tissues within the body. In this study, we present 5 distinct cases diagnosed with alkaptonuria. They have undergone 8 total joint replacement surgeries (4 hips and 4 knees) within 8 years (2010-2018). All patients had an excellent outcome over several years. The follow-up period ranged from 2 to 10 years. Although none of the presented cases had intraoperative or postoperative adverse sequelae, we must take care when dealing with patients with ochronotic arthropathy. They carry a higher risk of complications than other patients with osteoarthritis disease. These complications include fractures due to fragile bone quality, muscle or tendon rupture, joint instability, and anesthesia-related complications. Total joint arthroplasty is a valid and safe option in the management of hip and knee ochronotic arthropathy.
Keywords: Alkaptonuria; Arthroplasty; Hip replacement; Knee replacement; Ochronosis.
© 2020 Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons.
Figures
References
-
- Phornphutkul C., Introne W.J., Perry M.B., et al. Natural history of alkaptonuria. N Engl J Med. 2002;347(26):2111. - PubMed
-
- Ranganath L.R., Jarvis J.C., Gallagher J.A. Recent advances in management of alkaptonuria (invited review; best practice article) J Clin Pathol. 2013;66(5):367. - PubMed
-
- O’Brien W.M., La Du B.N., Bunim J.J. Biochemical, pathologic and clinical aspects of alkaptonuria, ochronosis and ochronotic arthropathy. Am J Med. 1963;34:813.
-
- Ventura-Ríos L., Hernández-Díaz C., Gutiérrez-Pérez L., et al. Ochronotic arthropathy as a paradigm of metabolically induced degenerative joint disease. A case-based review. Clin Rheumatol. 2016;35(5):1389. - PubMed
LinkOut - more resources
Full Text Sources